Insmed Inc (INSM)

[wjlknew]

I think PLH3465 makes a good point. Outside of Cephalon, assuming Iplex proves effective in ALS and assuming DNA and/or Tercica have no opt-in rights for ALS (which may not be the case), the only thing a partner can expect is a piece of half a pie. To me, that sounds like a bad deal for any prospective additional partner ... as well as a bad deal for Insmed. I would think any prospective additional partner would be better off buying Insmed out.

I wouldn't place much hope on any other partnerships.

Also, expecting a windfall from generic biologics is just wishful thinking. IF everything fall into place between Congress and the FDA, other (pronounced larger and richer) companies will step in to reap the profits. Perhaps a partner there, but the same logic applies regarding a buyout.

Let's face it. Half the farm is gone, but Dr. Allan's salary is intact regardless of what happens.